Press release
Diabetes Management Market to Reach USD 231.52 Billion by 2033, Growing at a CAGR of 23.39% | Straits Research
Diabetes Management Market Size
Diabetes continues to be one of the most prevalent chronic diseases worldwide. According to the International Diabetes Federation (IDF), one in every eleven adults aged 20-79 years approximately 463 million people are currently living with diabetes. To address this growing global concern, public and private organizations are increasingly adopting intervention programs such as lifestyle modification, educational campaigns, clinical management, and technology-driven solutions to improve diabetes care and outcomes.
Download Exclusive Research Report PDF Sample: (Including Full TOC, List of Tables & Figures, Chart) : https://straitsresearch.com/report/diabetes-management-market/request-sample
Market Dynamics
The growth of the diabetes management market is driven by improvements in healthcare systems and increased efforts toward effective management of diabetic patients. Diabetes management, largely dependent on primary care and lifestyle intervention, requires a strong role from community health providers. The IDF reports that nearly 10% of global healthcare expenditure (USD 760 billion) is allocated to diabetes care reflecting the urgency and investment in this field. Moreover, the continuous introduction of new and innovative treatments by leading market players is significantly contributing to market expansion.
Regional Analysis
North America dominates the global diabetes management market, led by the United States, Canada, and Mexico. The U.S. alone has approximately 34.2 million people living with diabetes, driving the demand for advanced self-management devices and healthcare services. Numerous Diabetes Self-Management Education and Support (DSMES) programs have been conducted nationwide, alongside initiatives by the CDC and National Diabetes Prevention Program (National DPP). In Canada, over 3 million adults are affected, and national initiatives like the Diabetes Prevention Program led by LMC Healthcare, Diabetes Canada, and INTERVENT International are advancing digital and lifestyle-based diabetes prevention efforts.
South America presents lucrative opportunities for market growth. In Brazil alone, more than 12 million people were living with diabetes as of 2017. The World Health Organization (WHO) and Brazil's Ministry of Health are implementing preventive and management programs and offering free medications to manage the disease. Similarly, Argentina is investing in diabetes awareness and advanced training programs to address the increasing prevalence of the condition.
Asia Pacific (APAC) is the fastest-growing regional market and is expected to maintain this trajectory through 2033. The IDF estimates that over 60% of global diabetic patients live in India and China. Factors such as rapid digital transformation, mobile health initiatives, and government-backed programs like India's mDiabetes, launched by the Ministry of Health and Family Welfare (MoHFW) and WHO, are promoting early diagnosis and self-management. In Japan, rising cases of Type 2 diabetes and cost-effective programs like Educational Hospitalization, which emphasize patient education and disease monitoring, are further boosting market growth.
For more insights and detailed analysis on the Market, visit : https://straitsresearch.com/report/diabetes-management-market
Europe is witnessing strong policy and government support for diabetes management. Approximately 59 million people aged 20-79 live with diabetes in the region, expected to rise to 68 million by 2045. National frameworks such as the National Service Framework (NSF) in England and Wales, Scottish Diabetes Framework, and Germany's Disease Management Programs (DMPs) are fostering systematic approaches for diabetes prevention and management.
In the Middle East and Africa, rising cases of Type 1 diabetes and increased government investment in research are driving the market. However, limited healthcare infrastructure in parts of Africa may restrict growth to some extent.
Segmental Overview
The global diabetes management market is segmented by device type and therapeutics.
Under device type, the market includes monitoring devices, diagnostic devices, and insulin delivery devices. The monitoring devices segment is expected to grow significantly due to rising diabetes prevalence and demand for self-monitoring tools such as blood glucose meters and lancets. The diagnostic devices segment comprising hemoglobin A1C kits and meters is in high demand for accurate, cost-effective testing. The insulin delivery devices segment, including pens, pumps, and syringes, is expanding rapidly, driven by product accessibility and ease of use.
The therapeutics segment is categorized into oral administered drugs and injectables. Human insulin and its analogs dominate this segment, with dipeptidyl inhibitors emerging as key contributors due to their safety and once-daily dosage convenience. Ongoing R&D efforts to develop more effective and safer drugs are further accelerating the therapeutics segment.
Download Exclusive Research Report PDF Sample: (Including Full TOC, List of Tables & Figures, Chart) : https://straitsresearch.com/report/diabetes-management-market/request-sample
Key Players
Abbott Laboratories
Bayer AG
Bristol-Myers Squibb
Eli Lilly and Co
Sanofi
Dexcom
Medtronic
Novo Nordisk A/S
Browse More Insights & Reports :
Digital Diabetes Management Market : https://straitsresearch.com/report/digital-diabetes-management-market
Osmotic Pumps Market : https://straitsresearch.com/report/osmotic-pumps-market
About Us
For over a decade, Straits Research has been a trusted partner to more than 2,000 small and large enterprises, empowering senior leaders and decision-makers with actionable intelligence to navigate complex markets. Our structured syndicate reports, published year-round, cover critical sectors such as chemicals, materials, food and beverage, healthcare, pharmaceuticals, automotive, technology, aerospace, and defense. Combined with our custom research tailored to client-specific needs, we deliver insights that drive business progress and informed decision-making.
Contact Us
Office 515 A, Amanora Chambers,
Amanora Park Town, Hadapsar,
Pune 411028, Maharashtra, India.
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Diabetes Management Market to Reach USD 231.52 Billion by 2033, Growing at a CAGR of 23.39% | Straits Research here
News-ID: 4237175 • Views: …
More Releases from Straits Research
Nuclear Medicine Market to Reach USD 40.19 Billion by 2033, Growing at a CAGR of …
According to a new report published by Straits Research, the global nuclear medicine market was valued at USD 15.46 billion in 2024 and is projected to increase from USD 17.19 billion in 2025 to USD 40.19 billion by 2033, expanding at a CAGR of 11.20% during the forecast period (2025-2033). The market growth is primarily driven by the rising incidence of chronic diseases, technological advancements in nuclear imaging, and increasing…
Oral Hygiene Market to Reach USD 76.34 Billion by 2033, Driven by Rising Awarene …
According to the latest report by Straits Research, the global oral hygiene market was valued at USD 50.93 billion in 2024 and is projected to reach USD 76.34 billion by 2033, expanding at a CAGR of 4.6% during the forecast period (2025-2033). The market growth is primarily fueled by the increasing prevalence of dental disorders, rising awareness of oral health, and continuous innovations by leading players in the oral care…
Personal Protective Equipment Market to Reach USD 158.75 Billion by 2033, Growin …
According to a new report by Straits Research, the global Personal Protective Equipment (PPE) Market was valued at USD 85.63 billion in 2024 and is projected to grow from USD 91.71 billion in 2025 to USD 158.75 billion by 2033, exhibiting a compound annual growth rate (CAGR) of 7.1% during the forecast period (2025-2033).
The market growth is primarily driven by increasing occupational safety concerns, the rising incidence of workplace accidents,…
Property Management Market Size Projected to Reach USD 52.99 Billion by 2033 gro …
As per Straits Research, the global property management market size was valued at USD 21.75 billion in 2024 and it is projected reach USD 52.99 billion by 2033, registering a CAGR of 10.4% during the forecast period (2025-2033). This growth is attributed to the increasing adoption of digital solutions and the rising demand for efficient property management practices across residential, commercial, and industrial real estate sectors. The evolution of property…
More Releases for Diabetes
Major Force in the Diabetes Pen Market 2025: Diabetes Fuels Surge In Demand For …
How Will the Diabetes Pen Market Grow, and What Is the Projected Market Size?
The diabetes pen market is projected to grow from $29.24 billion in 2024 to $31.22 billion in 2025, at a CAGR of 6.8%. Growth is fueled by the rising need for managing diabetes, advancements in diabetes care, and an increasing focus on patient-friendly medication administration tools.
The diabetes pen market is projected to grow strongly, reaching $40.17 billion…
Diabetes Monitoring Devices Market: Regaining Its Glory| Ascensia Diabetes Care, …
The Latest Study Published by HTF MI Research on the "Diabetes Monitoring Devices Market'' evaluates market size, trend and forecast to 2029. The Diabetes Monitoring Devices market study includes significant research data and evidences to be a practical resource document for managers and analysts is, industry experts and other key people to have an easily accessible and self-analysed study to help understand market trends, growth drivers, opportunities and upcoming challenges…
Prevalence of Diabetes Drives Opportunities for Type-2 Diabetes Market
The Type-2 Diabetes Market Analysis, 2023, by MarkNtel Advisors, presents a well-researched, detail-driven, and accurate study for the stakeholders. This analysis entails prominent aspects like trends, & recent developments, drivers, opportunities, challenges, & restraints, among other parameters, influencing the overall industry expansion across different locations. This report comprises data from historic years (2018-21) & the base year (2022) to put together an estimation of the forecast period (2023-28).
According to Type-2 Diabetes Market…
Reverse Diabetes with Dr. Merritt’s Diabetes Reversal Recipe
[November 26, 2020] – People suffering from diabetes always search for ways to lower blood sugar levels in their bodies. Diabetes treatment available costs you hundreds of dollars yearly and also restricts you to a diabetic diet. That hampers your mental health and well-being. Apart from this, eye problems, kidney failure, amputations are some of the physical problems diabetic patients face.
Dr. Marlene Merritt (from the Merritt Wellness Center in…
Diabetes Treatment
Diabetes Treatment is a important way to help manage the healthy ,easy to use and improve the way of the treatment of blood glucose monitoring system.
As living standards improve, an increasing obesity, the Diabetes Treatment has improved peoples living habits, disease control effect, is becoming more and more important.
The global Diabetes Treatment market is valued at 43700 million US$ in 2018 and will reach 58000 million US$ by the end…
Self-Monitoring Blood Glucose Devices Market Study by Advance Application [Type …
The global self-monitoring blood glucose devices market was valued at $7,768 million in 2017 and is projected to reach $10,828 million by 2025 at a CAGR of 4.2% from 2018 to 2025. Monitoring of blood glucose is an essential step in diabetes management. Blood glucose monitoring devices are predominantly used to monitor a patient’s blood glucose level. Self-monitoring blood glucose (SMBG) devices are easy-to-use and enable people to monitor their…
